1 Min Read
Aug 30 (Reuters) - QRxPharma Ltd
* FY revenue from ordinary activities $8,141, down 49 percent
* FY net loss attributable to members $422,282 versus loss of $1.8 million Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.